Foresight Diagnostics
Nathan Valverde is a seasoned professional in business development within the biopharmaceutical sector, currently serving as the Director of Business Development at Foresight Diagnostics Inc. Previous roles include Director and Associate Director of Biopharma Business Development at Foundation Medicine, as well as Licensing Manager at Mass General Brigham Innovation. Nathan also held the position of R&D Transactions Manager in External Innovation at Sanofi. Nathan Valverde obtained a Juris Doctor (J.D.) in Intellectual Property from UNH Franklin Pierce School of Law and a Bachelor of Science (B.S.) in Biology from Arizona State University.
This person is not in any offices
Foresight Diagnostics
1 followers
Foresight Diagnostics is the world’s most sensitive liquid biopsy minimal residual disease (MRD) test that detects the earliest hints of cancer relapse.